CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Otsuka Holdings Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Otsuka Holdings Co Ltd
Shinagawa Grand Central Tower
2-16-4, Konan
Phone: +81 367171410p:+81 367171410 MINATO-KU, TKY  108-8241  Japan Ticker: 45784578

Business Summary
Otsuka Holdings Co., Ltd. is a Japan-based company mainly engaged in the medical and nutraceuticals related business and other businesses. The Company operates through four business segments. The Medical-related segment is engaged in the sale of ethical drugs, and the research development and export of therapeutic drugs. The Nutraceuticals-related segment is engaged in the manufacture, purchase and sale of nutraceuticals-related products, such as functional food and dietary supplements. The Consumer-related segment is engaged in the manufacture and sale of consumer products and mineral water. The Others segment is engaged in the manufacture and sale of chemical products, the manufacture, sale and import of measuring equipment, and the manufacture of synthetic resin molding products.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023Yes---Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Representative Director IchiroOtsuka 58 3/1/2022 7/1/2008
President, Chief Executive Officer, Chairman of the Board of Subsidiary, Representative Director TatsuoHiguchi 72 3/1/2020 7/1/2008
Chief Financial Officer, Director YukoMakino 61 3/1/2019 9/1/2016
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Otsuka Pharmaceutical India Private Limited 21st Floor, West Gate, Tower - B Ahmedabad India
PT Amerta Indah Otsuka ROOM701-702 JI.SULTANISKANDAR JAKARTA Indonesia
Otsuka Pakistan Ltd 30-B KARACHI Pakistan
16 additional Subsidiary records available in full report.

Business Names
Business Name
4578
Astex Pharmaceuticals Inc
Autumn Acquisition Corporation
22 additional Business Names available in full report.

General Information
Number of Employees: 34,388 (As of 12/31/2023)
Outstanding Shares: 542,686,037 (As of 12/31/2023)
Shareholders: 85,818
Stock Exchange: TYO
Fax Number: +81 367171409


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024